Author

N. Abi-Gerges

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:electrophysiology· 1

Frequent Co-Authors

A. C. Kruegel· 1 shared A. Ghetti· 1 shared A. Hodges· 1 shared A. Hunkele· 1 shared A. Khan· 1 shared A. Ranjan· 1 shared B. Bechand· 1 shared C. Hwu· 1 shared

Activity by Year

2021-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. C. Kruegel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cyclin A2 Induces Cytokinesis in Human Adult Cardiomyocytes and Drives Reprogramming in Mice

E. Bouhamida, S. Vadakke-Madathil, P. Mathiyalagan, A. Ranjan, A. Khan, C. Sherman, P. E. Miller, A. Ghetti, N. Abi-Gerges, H. W. Chaudhry

This study shows that Cyclin A2 induces cytokinesis in adult human cardiomyocytes and drives reprogramming in mice through transcriptomic analysis.

npj Regenerative Medicine · Nov 3, 2025Peer-reviewedCell Biology

Ion channel expression and electrophysiology of singular human (primary and induced pluripotent stem cell derived) cardiomyocytes

C. Schmid, N. Abi-Gerges, D. Zellner, G. Rast

This study examines ion channel expression and electrophysiology in human primary and induced pluripotent stem cell-derived cardiomyocytes, revealing mixed cardiac cell-type traits and their implications for drug testing.

Cells · Nov 30, 2021Peer-reviewedPharmacology & Toxicology

Novel Class of Psychedelic Iboga Alkaloids Disrupts Opioid Addiction States

V. Havel, A. C. Kruegel, B. Bechand, S. McIntosh, L. Stallings, A. Hodges, M. G. Wulf, M. Nelson, A. Hunkele, M. Ansonoff, J. E. Pintar, C. Hwu, N. Abi-Gerges, S. A. Zaidi, V. Katritch, , D. Sames

This paper introduces a new class of iboga alkaloids, oxa-iboga, which show therapeutic efficacy in opioid use disorder without cardiac risks, as demonstrated in rat models.

bioRxiv · Jul 22, 2021 · PreprintPharmacology & Toxicology